BRCA-Mutated Breast Carcinoma (DBCOND0167914)

Identifiers

Synonyms

Not Available

Associated Data

Indicated Drugs and Targets

Not Available

Clinical Trials

Identifier	Title	Drug(s)	Purpose	Phase	Status
NCT06516289	Neoadjuvant Treatment of gBRCA-Mutated HER2-Negative Breast Cancer With HRS-1167 and Famitinib ± Camrelizumab	Camrelizumab Famitinib HRS-1167	treatment	2	not_yet_recruiting